Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP ...

The idea is that most prostate cancers grow so slowly that they won't cause symptoms or shorten your lifespan, even if they’re left untreated. Prostate cancer treatments, on the other hand, can cause ...

Read more about how low testosterone levels are linked to ‘extreme’ disease progression in patients with prostate cancer ...

Why would any healthy person, newly diagnosed with cancer, elect not to undergo curative treatment? Newly diagnosed prostate cancer patients presented with the option of active surveillance often ask ...

At 25 years, the prostate cancer-specific survival rate was 94% among men with screen-detected prostate cancer who chose primary active surveillance – but prostate cancer progression rates are high.

DEAR DR. ROACH: I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

Basal-luminal classifiers, such as PAM50, may predict prostate cancer grade progression risk in men with low- to intermediate-risk prostate cancer who are considering active surveillance.

USA: A retrospective cohort study has found that low testosterone levels in patients with prostate cancer undergoing active ...

Active surveillance for low-risk prostate cancer, which involves forgoing immediate treatment, has increased threefold since such "conservative" management was recommended by major guidelines in the ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every eight American men will be diagnosed with prostate cancer at some point, an ...